RXO to Be Acquired for $30.25/Share in Cash-and-Stock Deal with CHRW
RXO has more than doubled off its 52-week low of $10.425 on elevated volume (2.0× avg).
Summary
RXO agreed to be acquired for $30.25 per share, consisting of $17.25 in cash and 0.0856 shares of CHRW per RXO share, with alternative consideration of $30.25 cash or 0.1992 CHRW shares per RXO share, subject to proration. The deal is approximately 57% cash and 43% stock, giving RXO holders about 11% of the combined company. C.H. Robinson will buy RXO for about $5 billion. Closing is targeted for H1 2027, subject to regulatory and shareholder approvals. MFN Partners, which holds 17.04% of RXO, has agreed to vote in favor and retain its RXO shares. This is a definitive merger agreement with a significant premium to the current price of $28.37, representing a material corporate event that will likely drive immediate repricing. The transaction follows a period of improving fundamentals, including strong Q2 results and better-than-expected Q3 truckload gross profit per load. Watch for the proxy statement and any regulatory review updates.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — The 8-K details merger consideration: $17.25 cash plus 0.0856 CHRW shares, or $30.25 cash, or 0.1992 CHRW shares per RXO share, with proration; MFN Partners holds 17.04% and agreed to vote in favor.
At the time of this announcement, RXO was trading at $28.37 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $10.43 to $29.90. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.